| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.21 | 7e-05 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.0001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.0008 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0009 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |